Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · IEX Real-Time Price · USD
4.620
+0.140 (3.12%)
At close: Apr 26, 2024, 4:00 PM
4.520
-0.100 (-2.16%)
After-hours: Apr 26, 2024, 5:46 PM EDT
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of $265.82 million as of April 26, 2024. Its market cap has decreased by -24.37% in one year.
Market Cap
265.82M
Enterprise Value
-115.43M
1-Year Change
-24.37%
Ranking
Category
Stock Price
$4.62
Market Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $265.82M, an increase of 26.88%. That is a compound annual growth rate of 1.33%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 265.80M | 3.10% |
Apr 25, 2024 | 257.80M | -1.75% |
Apr 24, 2024 | 262.40M | -1.50% |
Apr 23, 2024 | 266.40M | -3.55% |
Apr 22, 2024 | 276.20M | -6.05% |
Apr 19, 2024 | 294.00M | 2.80% |
Apr 18, 2024 | 286.00M | -5.14% |
Apr 17, 2024 | 301.50M | 29.40% |
Apr 16, 2024 | 233.00M | -0.26% |
Apr 15, 2024 | 233.60M | -1.48% |
Apr 12, 2024 | 237.10M | -3.74% |
Apr 11, 2024 | 246.30M | - |
Apr 10, 2024 | 246.30M | -1.83% |
Apr 9, 2024 | 250.90M | -3.31% |
Apr 8, 2024 | 259.50M | -6.42% |
Apr 5, 2024 | 277.30M | -2.05% |
Apr 4, 2024 | 283.10M | -2.58% |
Apr 3, 2024 | 290.60M | 29.16% |
Apr 2, 2024 | 225.00M | -5.10% |
Apr 1, 2024 | 237.10M | 0.25% |
Mar 28, 2024 | 236.50M | 5.67% |
Mar 27, 2024 | 223.80M | 0.77% |
Mar 26, 2024 | 222.10M | -0.27% |
Mar 25, 2024 | 222.70M | -0.49% |
Mar 22, 2024 | 223.80M | -0.53% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Prelude Therapeutics | 271.08M |
Sutro Biopharma | 270.76M |
EDAP TMS | 269.00M |
Acrivon Therapeutics | 264.57M |
Enanta Pharmaceuticals | 264.56M |
Cybin | 260.88M |
Sight Sciences | 260.16M |
Invivyd | 259.31M |